发明授权
- 专利标题: Glycopegylated erythropoietin
- 专利标题(中): 糖基化促红细胞生成素
-
申请号: US13157575申请日: 2011-06-10
-
公开(公告)号: US08916360B2公开(公告)日: 2014-12-23
- 发明人: Shawn DeFrees , David A. Zopf , Caryn Lang Bowe
- 申请人: Shawn DeFrees , David A. Zopf , Caryn Lang Bowe
- 申请人地址: DK Bagsvaerd
- 专利权人: Novo Nordisk A/S
- 当前专利权人: Novo Nordisk A/S
- 当前专利权人地址: DK Bagsvaerd
- 代理机构: Leydig, Voit & Mayer, Ltd.
- 主分类号: C12P21/06
- IPC分类号: C12P21/06 ; A61K38/18 ; A61P7/06 ; C07K14/505 ; A61K38/14 ; C12P21/00 ; A61K38/22 ; A61K38/00
摘要:
The present invention provides conjugates between erythropoietin and PEG moieties. The conjugates are linked via an intact glycosyl linking group interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from glycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto a glycosyl residue on the peptide. Also provided are methods for preparing the conjugates, methods for treating various disease conditions with the conjugates, and pharmaceutical formulations including the conjugates.
公开/授权文献
- US20120107867A1 GLYCOPEGYLATED ERYTHROPOIETIN 公开/授权日:2012-05-03
信息查询